|
|
Article: PHARMACIA & UPJOHN, INC. RECEIVES FDA CLEARANCE TO MARKET PHADIATOP INHALANT ALLERGY TEST
- Article from:
- PR Newswire
- Article date:
- March 6, 1996
|
Copyright informationCOPYRIGHT 1996 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WASHINGTON, March 6 /PRNewswire/ -- Pharmacia & Upjohn, Inc. (NYSE: PNU) announced today that the U.S. Food and Drug Administration (FDA) has recommended marketing clearance for Phadiatop -- a yes/no blood test for the determination of inhalant allergy. It is estimated that over 30% of the population suffers from allergy symptoms.
"We are delighted to be able to offer physicians and laboratories a blood test that may determine whether a patient's symptoms are being caused by allergy or by a cold," said Mark D. Myslinski, General Manager for the Diagnostics Division of Pharmacia & Upjohn, Inc. "Since the symptoms are so similar, our product will help physicians to accurately ...
Related newspaper, magazine, and journal articles:
|